Clinical Trial: Cannabis Oil Effective at Improving Sleep in Adults with Insomnia

Sixty percent of the participants in the intervention group were "no longer classified as clinical insomniacs" at the conclusion of the trial.

Investigators summarized, "Due to its effectiveness and convenience, medical marijuana therapy may be helpful for patients suffering from migraines."

DC: Council Members Advance Legislation to Expunge Marijuana Convictions Details

12/22/22 3:30pm UTC

No Further Movement Expected on SAFE Banking, Other Marijuana Reforms ... Details

12/20/22 12:45pm UTC

Federally Funded Study Finds Teen Use Rates Largely Unchanged by Legalization Details

12/19/22 9:21pm UTC

Ohio: Lawmakers Advance Sentencing Reform Bill to Governor's Desk Details

12/16/22 5:11pm UTC

Kansas City: Officials Dismiss Hundreds of Marijuana Cases Following Vote Details

12/16/22 4:20pm UTC

Researchers said that their study was among the "largest and longest real-world analysis of the efficacy and safety" of medical cannabis products.

"No cardiovascular treatment-emergent adverse drug effects emerged" during patients' treatment with liquid cannabis extracts.

Patients with anxiety disorders are eligible to access medical cannabis products on January 1, 2023.

NORML REPORTS

NORML IN THE MEDIA

NORML OP-ED: "Democrats blew the opportunity for federal cannabis reform"
LEARN: New NORML report highlights nearly 2 million marijuana-related pardons and expungements
FEDERAL: Marijuana banking, other reforms absent from 2023 omnibus spending bill
READ: New study finds that marijuana legalization results in far fewer overall arrests than does decriminalization
MASSACHUSETTS: New marijuana and driving curriculum to be taught to teens, but is the information accurate?